Meeting
2015 ASCO Annual Meeting
Comprehensive characterization of PDL-1 and CTLA-4 in gastric cancer.
Authors
Hans Anton Schloesser
Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany
Hans Anton Schloesser , Uta Drebber , Martin Thelen , Michael Kloth , Sasha Rothschild , Maria Garcia-Marquez , Sharam Zoghi , Alexander Urbanski , Hakan Alakus , Astrid Schauss , Sebastian Theurich , Ute Warnecke-Eberz , Dirk Ludger Stippel , Arnulf Heinrich Hölscher , Thomas Zander , Stefan Paul Moenig , Michael S. von Bergwelt-Baildon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 4056)
DOI
10.1200/jco.2015.33.15_suppl.4056
Abstract #
4056
Poster Bd #
166
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Presence of CD8+ cytotoxic T-cells in proximity to tumor cells, TIM3, CTLA-4 and prognostic implications for muscle-invasive urothelial cancer.
First Author: Nicolaus F. Debatin
Poster
2022 ASCO Annual Meeting
LAG3 transcriptomic expression correlates with high levels of PD-1, PD-L1, PD-L2, and CTLA-4 checkpoints and with high tumor mutational burden across cancers.
First Author: Jacob J. Adashek
Poster
2022 ASCO Annual Meeting
Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
First Author: Annika Lenz
Poster
2022 ASCO Genitourinary Cancers Symposium
Association of leucocyte levels in urine with tissue PD-L1 status and immune infiltration into basal bladder cancer subtype in the prospective real-world clinicopathological register trial Bladder BRIDGister.
First Author: Thorsten Ecke